Cargando…

Immunomodulatory treatment of interstitial lung disease

Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array of immunomodulatory treatment options compared with IPF, due to their inflammatory component. However, there is a relative paucity of guidance on the management of this heterogeneous group of diseases. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Bosch, Laura, Luppi, Fabrizio, Ferrara, Giovanni, Mura, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364223/ https://www.ncbi.nlm.nih.gov/pubmed/35938712 http://dx.doi.org/10.1177/17534666221117002

Ejemplares similares

Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
por: Cassone, Giulia, et al.
Publicado: (2020)

Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases
por: Holtze, Colin, et al.
Publicado: (2018)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management
por: Luppi, Fabrizio, et al.
Publicado: (2021)

Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases
por: MANFREDI, Andreina, et al.
Publicado: (2020)

Erratum to acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature
por: Manfredi, Andreina, et al.
Publicado: (2020)

A Retrospective, Descriptive Study of Dyspnea Management in a Multidisciplinary Interstitial Lung Disease Clinic
por: van den Bosch, Laura, et al.
Publicado: (2022)

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
por: Vacchi, Caterina, et al.
Publicado: (2020)

Sexual Dimorphism in Interstitial Lung Disease
por: Ozaki, Mari, et al.
Publicado: (2022)

Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
por: Yasuoka, Hidekata
Publicado: (2016)

Lung transplantation for interstitial lung disease
por: Kapnadak, Siddhartha G., et al.
Publicado: (2021)

Interstitial Lung Disease
Publicado: (1982)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
por: Vacchi, Caterina, et al.
Publicado: (2021)

Interstitial lung diseases in children
por: Clement, Annick, et al.
Publicado: (2010)

Telomeres in Interstitial Lung Disease
por: Stock, Carmel J. W., et al.
Publicado: (2021)

Smoking and interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2015)

Comorbidities in interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2017)

The genetics of interstitial lung diseases
por: Borie, Raphael, et al.
Publicado: (2019)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association
por: Sebastiani, Marco, et al.
Publicado: (2021)

Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Kawasumi, Hidenaga, et al.
Publicado: (2015)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Faverio, Paola, et al.
Publicado: (2021)

Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential
por: Sebastiani, Marco, et al.
Publicado: (2020)

Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
por: Vacchi, Caterina, et al.
Publicado: (2021)

Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?
por: Kalluri, Meena, et al.
Publicado: (2021)

“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease
por: Sgalla, Giacomo, et al.
Publicado: (2018)

Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Diagnosis and management of interstitial lung disease
por: Meyer, Keith C
Publicado: (2014)

Respiratory bronchiolitis-interstitial lung disease
por: Sieminska, Alicja, et al.
Publicado: (2014)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Interstitial Lung Diseases in Developing Countries
por: Rivera-Ortega, Pilar, et al.
Publicado: (2019)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis
por: Peters, Linsey J. F., et al.
Publicado: (2021)

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
por: Cottin, Vincent
Publicado: (2019)

Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis
por: Dei, Giulia, et al.
Publicado: (2020)

Genetic testing in diffuse parenchymal lung disease
por: Spagnolo, Paolo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e7htcg9aplu19gafjicu32sftl